
						
							
						
						
							<!--
							google_ad_client = "pub-5806585833518451";
							/* 300x250, created 6/2/09 - iposol_ipo_detail_top */
							google_ad_slot = "4379562531";
							google_ad_width = 300;
							google_ad_height = 250;
									-->
							
							
							
						

						Incorporated in 1993, Bajaj Healthcare Ltd is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs).Currently they operate five (5) manufacturing units. Company's present product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal & Bacteriostatic, Diuretic & Vasodilator, Mineral& Nutritional supplements, Bronchodilater / Anti-asthmatic and Nootropics. Their Formulations unit manufactures tablets, capsules and sachets for their own brands as well as under Loan License (job work) for other pharmaceutical companies. Currently, they manufacture formulations for GlaxoSmithKline Pharmaceuticals Limited (GSK) and USV Limited (USV) on a Loan License basis. Bajaj Healthcare supply their APIs and FDFs both domestically and exporting to various countries in regions like, Europe, USA, Australia, Africa, South America, etc.

						

						Company Promoters:The promoters of the company are:1.  Mr. Sanjankumar R. Bajaj

						

						
							<!--
								google_ad_client = "pub-5806585833518451";
								/* 300x250, created 9/3/09 - IPO Detail Center */
								google_ad_slot = "7910498455";
								google_ad_width = 300;
								google_ad_height = 250;
								-->
							
							
							
						

						Objects of the Issue:The Objects of the Issue are to:1. Repayment of loans; and2. Funding expenditure for General Corporate Purposes.

						Issue Detail:
						  »»  Issue Open: Apr 27, 2016 - May 2, 2016
							  »»  Issue Type: Fixed Price Issue IPO
							  »»  Issue Size: 1,817,600 Equity Shares of Rs 10 aggregating up to Rs 30.90 Cr
							
							
							  »»  Face Value: Rs 10 Per Equity Share
							  »»  Issue Price: Rs. 170 Per Equity Share
							  »»  Market Lot: 800 Shares
							  »»  Minimum Order Quantity: 800 Shares
							  »»  Listing At: BSE SME
						

						


						
						Bajaj Healthcare IPO Reviews:
						
							
							Bajaj Healthcare Ltd IPO review by Dilip Davda
							
						
						


						
							
						

						
							
						
					
